awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38645792-4C73C512-1932-4740-BF94-DE6CD90FE6F1
Q38645792-4C73C512-1932-4740-BF94-DE6CD90FE6F1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38645792-4C73C512-1932-4740-BF94-DE6CD90FE6F1
Emerging use of combination therapies for the management of type 2 diabetes - focus on saxagliptin and dapagliflozin.
P2860
Q38645792-4C73C512-1932-4740-BF94-DE6CD90FE6F1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38645792-4C73C512-1932-4740-BF94-DE6CD90FE6F1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0f4ca4d83f9c7b24bc98e1f56ddab08743443426
P2860
Clinical Pharmacokinetics and Pharmacodynamics of Saxagliptin, a Dipeptidyl Peptidase-4 Inhibitor.